OpenAI Launches GPT-Rosalind, an AI Model for Drug Discovery Research
OpenAI launched GPT-Rosalind, an AI model for accelerating drug discovery, available as a research preview to enterprise users like Amgen and Moderna. It aids in scientific reasoning and aims to shift OpenAI's business model toward sharing drug development risks.
GateNews·04-17 01:22
